Nemtabrutinib Recruiting Phase 2 Trials for Chronic Lymphocytic Leukemia / Hematological Malignancy / Non-Hodgkin's Lymphoma (NHL) / Waldenström's Macroglobulinemia (WM) Treatment

Indications	Status	Purpose	Phase
DBCOND0028332 (Chronic Lymphocytic Leukemia) DBCOND0031698 (Hematological Malignancy) DBCOND0030854 (Non-Hodgkin's Lymphoma (NHL)) DBCOND0092565 (Waldenström's Macroglobulinemia (WM))	Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT04728893	Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)	Nemtabrutinib (DB18866)